Subclinical Macular Changes and Disease Laterality in Pediatric Coats Disease Determined by Quantitative Optical Coherence Tomography Angiography by Schwartz, R et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/retinajournalby
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3Y
eLE
A
Q
tdJ82U
r1FcdpIZ1Y
B
+m
ZrU
m
iw
oFm
Y
qw
goH
3H
C
tLIuLU
kD
C
dg==
on
09/22/2018
Downloadedfromhttps://journals.lww.com/retinajournalbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3YeLEAQtdJ82Ur1FcdpIZ1YB+mZrUmiwoFmYqwgoH3HCtLIuLUkDCdg==on09/22/2018
SUBCLINICAL MACULAR CHANGES AND
DISEASE LATERALITY IN PEDIATRIC
COATS DISEASE DETERMINED BY
QUANTITATIVE OPTICAL COHERENCE
TOMOGRAPHY ANGIOGRAPHY
ROY SCHWARTZ, MD,* SOBHA SIVAPRASAD, FRCOPHTH,* REBECCA MACPHEE, BSC,*
PATRICIA IBANEZ, BSC,* PEARSE A. KEANE, FRCOPHTH,* MICHEL MICHAELIDES, FRCOPHTH,*
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Purpose: To determine vascular change at the macula in both eyes in unilateral pediatric
Coats disease using optical coherence tomography angiography.
Methods: Retrospective case-series. Thirteen eyes of pediatric patients with a diagnosis
of unilateral Coats disease of various stages were compared with 13 fellow eyes. Optical
coherence tomography angiography images were acquired using the RTVue XR Avanti.
Scans were analyzed with novel projection artifact removal software and improved
segmentation. Vascular density and foveal avascular zone area were calculated.
Results: Vascular density was signiﬁcantly decreased in eyes with Coats disease in
comparison with fellow eyes in both the superﬁcial capillary plexus and deep capillary
plexus (43.7 ± 4.7 vs. 45.9 ± 4.4 [P = 0.000] and 43.0 ± 6.3 vs. 50.3 ± 2.2 [P = 0.001],
respectively). The difference was also signiﬁcant for most sectors of the macula. Foveal
avascular zone area was signiﬁcantly larger in eyes with Coats disease in comparison with
fellow eyes (0.29 ± 0.1 vs. 0.24 ± 0.09 [P = 0.003]). These signiﬁcant differences appeared
as early as Stage 2A, preceding clinical ﬁndings.
Conclusion: The ﬁndings support the unilaterality of Coats disease and show that
vascular changes on optical coherence tomography angiography precede clinical staging
of the condition.
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Coats disease is a rare, predominantly unilateralretinal vascular developmental disorder character-
ized by retinal telangiectasia, areas of peripheral avas-
cular retina, vascular leakage, and exudation resulting
in visual impairment.1 It predominantly affects males,
with an average age of onset of ﬁve years. The severity
of the condition is classiﬁed based on funduscopic
examination or color fundus photographs.2 Stage 1 is
characterized by the presence of retinal telangiectasias
only. In Stage 2, exudation accompanies telangiecta-
sia, either extrafoveally (Stage 2A) or foveally (Stage
2B). In Stage 3, there is exudative retinal detachment,
which can be subtotal (Stage 3A) or total (Stage 3B).
In Stage 4, the condition advances to a total retinal
detachment and glaucoma, whereas Stage 5 represents
advanced end-stage disease. Recently, Daruich et al3
have suggested a change to the classiﬁcation, further
dividing Stage 2B into 2B1 and 2B2, with the latter
including a subfoveal nodule and the former lacking
this feature. Fluorescein angiography is the conﬁrma-
tory diagnostic test used to conﬁrm the diagnosis.
Angiographic features include the presence of unilat-
eral telangiectatic and light bulb aneurysmal vessels
and peripheral retinal capillary nonperfusion, whereas
macular ﬁndings include dilated capillaries, capillary
closure, microaneurysms, and leakage.4–6
Adult cases of Coats disease are similar in terms of
unilateral clinical presentation and disease course, but
generally have a more limited area of retinal involve-
ment and slower disease progression.7 Indeed, it has
been shown that an inverse relationship exists between
age at presentation and the severity of disease.8
The exact mechanism of the disease is unknown.
It is thought to be a nonhereditary disease and
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probably caused by a somatic mutation of the Norrie
disease protein gene.9 However, with the advent of
wide-ﬁeld imaging, there have been reports that
Coats disease may be a bilateral disease because of
the presence of peripheral vascular changes in the
fellow eyes.10,11 Such peripheral changes may also
be seen in healthy eyes, further confounding the
matter.12 Bilaterality also questions whether there
is a hereditary element to the condition. Therefore,
it is important to study the macula in Coats disease
in more detail to better understand the laterality of
the condition.
Optical coherence tomography angiography
(OCTA) is a novel and noninvasive technique for
demonstrating the microvascular blood ﬂow within the
macula. It produces depth-resolved evaluation of the
reﬂectance data from retinal tissue, providing a three-
dimensional volume of information.13 Its noninvasive-
ness and speed of use are advantageous in the pediatric
population. In addition, development of handheld de-
vices show promise for their use in neonates and in the
setting of examination under anesthesia.14,15 A limited
number of previous studies described qualitative
OCTA ﬁndings in Coats disease, predominantly in
the adult population, with no mention of disease
stage.16–19
Recently, different quantiﬁcation algorithms have
been used to extract angiographic data, including
vascular density and the area of the foveal avascular
zone (FAZ), from OCTA scans.20,21 The aim of this
study was to quantify vascular density at the
macula and FAZ area in a pediatric population with
different stages of unilateral Coats disease and
compare these parameters with those of the fellow
eyes to determine whether there is any evidence to
the laterality of the disease based on macular
ﬁndings.
Methods
Institutional review board committee approval was
obtained for the study. Pediatric patients with a diag-
nosis of Coats disease who underwent OCTA of both
eyes at the pediatric clinic of Moorﬁelds Eye Hospital
between May 2016 and October 2017 were retrospec-
tively evaluated. Data collected included ﬁndings of
ophthalmologic examination, best-corrected visual
acuity (in logarithm of the minimal angle of resolu-
tion) as measured by specialist orthoptists, and OCTA
data.
Inclusion and Exclusion Criteria
Pediatric patients with the diagnosis of unilateral
Coats disease based on clinical examination and
conﬁrmed on examination under anesthesia and ﬂuo-
rescein angiography (under anesthesia) were retro-
spectively enrolled. Patients were excluded if they had
a systemic disease or another retinal pathology.
Optical Coherence Tomography Angiography
Image Acquisition
Optical coherence tomography angiography images
were acquired using the RTVue XR Avanti spectral
domain OCT device with AngioVue software (Opto-
vue, Fremont, CA). This system uses an SSADA
software algorithm (version 2016.2.0.35) with a high
speed of 70,000 axial scans per second, wavelength of
840 nm, and an axial resolution of 5 mm to acquire
OCTA volumes consisting of 304 · 304 A-scans. The
scanning area was captured in 3 · 3 mm sections
centered on the fovea, capturing both eyes of each
subject. Acquisition of scans was performed in clinic,
after disease stabilization.
Optical Coherence Tomography Angiography
Image Analysis
Image analysis was performed using a noncommer-
cially available version of the AngioAnalytics soft-
ware (version 2017.1.0.144), which was very similar
to the future commercial version. This software uses
a proprietary three-dimensional projection artifact
removal algorithm (3D PAR), allowing for the
removal of projection artifacts from deeper layers.
The algorithm removes projection artifacts from the
OCTA volume on a per voxel basis, using information
from the OCT and OCTA volume to differentiate in
situ OCTA signal from projection artifacts.
The software segments the macular vasculature into
a superﬁcial capillary plexus (SCP), extending from
the internal limiting membrane to the inner plexiform
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layer 2 10 mm. Similarly, the deep capillary plexus
(DCP) is segmented from the inner plexiform layer 2
10 mm to the outer plexiform layer + 10 mm. The
software allows for manual editing of segmentation
lines and propagation of the change over the selected
region of interest in areas where automated segmenta-
tion is incorrect. The segmentation was carefully
examined for each case and corrected as needed to
delineate the appropriate layers, including in cases of
anatomical complications (i.e., edema or scarring)
(Figure 1).
The software assigns a scan quality measure to each
image, ranging from 1 to 10. Images with a scan
quality ,6 (due to motion or blink artifacts, lack of
focus, etc.) or with otherwise poor image quality (i.e.,
due to vessel doubling, cropping, or low signal due to
ﬂoaters) were excluded from the study.
Using the automated software, vascular density was
measured using a partial Early Treatment Diabetic
Retinopathy Study grid overlay that is superimposed
on the automatically detected center of the fovea to
generate vascular density in different areas of interest.
The grid centration was adjusted manually when
needed. It is composed of two circles: an inner circle
with a diameter of 1 mm, covering the foveal region;
and an outer circle with a diameter of 3 mm,
corresponding to the parafovea. The outer circle is
divided into sectors (nasal, temporal, superior, and
inferior). For each predeﬁned region, vascular density
is calculated as percentage of the area occupied by
vessels out of all region area (Figure 2).
The FAZ area parameter is calculated automati-
cally by the software, and the detection boundary is
based on inner plexiform layer to outer plexiform
layer + 10 mm slab. In cases of incorrect automatic
delineation, manual delineation adjustment was
made.
Statistical Analysis
Continuous variables were tested for normality
distribution (Shapiro–Wilk test). The paired t-test or
Wilcoxon nonparametric test was used to compare the
logarithm of the minimal angle of resolution visual
acuity, vascular density, and FAZ area between eyes
with Coats disease and fellow eyes. The Pearson or
Spearman correlation coefﬁcients were used to study
the correlation between logarithm of the minimal angle
of resolution visual acuity, vascular density, and FAZ
Fig. 1. Manual segmentation of an OCTA scan of the right eye of an 8-
year-old patient with Stage 2B Coats disease. The patient had a central
subfoveal scar, necessitating manual segmentation of the layers on the
OCTA B-scan (bottom of image). The red and green lines delineate the
superﬁcial capillary plexus, as manually adjusted to bypass the scar.
The top image is the resultant en face optical coherence tomography
angiography scan.
Fig. 2. Macular vascular density measurement in the left eye of a 17-
year-old patient with Stage 2A Coats disease. A 3 · 3 mm optical
coherence tomography angiography scan of the macula at the level of
the superﬁcial capillary plexus. The vascular density is measured in the
whole image and in each sector of the grid.
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area. A P value of ,0.05 was considered statistically
signiﬁcant.
Statistical analyses were performed with SPSS-25
IBM, Armonk (NY, USA).
Results
Patient characteristics are listed in Table 1. A total
of 26 eyes of 13 patients (11 male and 2 female)
were included in the study. The mean age was
11.6 ± 2.7 (range 8–17) years. The mean age at time
of diagnosis was 8.9 ± 4.0 years. Five patients had
Stage 2A disease, 7 had Stage 2B, and 1 had Stage
3A. Two of the patients with Stage 2B disease had
macular pathology that required manual segmenta-
tion of retinal layers due to cystoid macular edema
and a macular scar (Figure 1). Notably, the patient
with a macular scar had a nodule before develop-
ment of the scar and was therefore Stage 2B2. The
rest were Stage 2B1.
Vascular density and FAZ values are presented in
Table 2. Vascular density was signiﬁcantly decreased
in eyes with Coats disease in comparison with fellow
eyes in the whole SCP and DCP images (43.7 ± 4.7 vs.
45.9 ± 4.4 [P = 0.000] and 43.0 ± 6.3 vs. 50.3 ± 2.2 [P
= 0.001], respectively). The difference was also sig-
niﬁcant for all sectors of the SCP and DCP except for
the fovea in the SCP layer. The FAZ area was signif-
icantly larger in eyes with Coats disease in comparison
with fellow eyes (0.29 ± 0.1 vs. 0.24 ± 0.09 [P =
0.003]).
Two patients with Stage 2B disease had macular
edema or scarring, necessitating manipulation of the
automatic segmentation performed by the OCTA
algorithm. To rule out possible skewing of data due
to these signiﬁcant changes, data analysis was also
performed for the other 11 patients only. For this
group of patients, the statistical signiﬁcance re-
mained the same except for the inferior parafoveal
region of the SCP layer, for which the difference
between eyes with Coats disease and fellow eyes
became borderline signiﬁcant (P = 0.056).
Table 3 shows vascular density and FAZ data for
the ﬁve patients with Stage 2A disease and Table 4
presents these data for the seven patients with Stage
2B disease. In the group of patients with Stage 2A
disease, there were no signiﬁcant differences in vas-
cular density at the level of the SCP except for the
temporal parafoveal area. However, most sections in
the DCP layer (except for the inferior hemifovea,
nasal, and temporal parafoveal areas) showed a sig-
niﬁcant decrease in vascular density in Coats eyes in
comparison with fellow eyes. The FAZ area was also
larger in the eyes with Coats disease (0.29 ± 0.1 vs.
0.25 ± 0.1, P = 0.012). In comparison, in the group
of patients with Stage 2B disease, vascular density
was decreased in both the SCP and DCP layers in
almost all segments (except for the fovea and infe-
rior parafovea in the SCP layer). The FAZ area was
larger in eyes with Coats disease (0.31 ± 0.1 vs. 0.25
± 0.1, P = 0.046).
Table 1. Patient Characteristics of the Study Population
(N = 14)
No. of Coats eyes 13
No. of fellow eyes 13
Sex (male) 11
Age (SD) 11.6 ± 2.7
Disease stage
2A 5
2B 7
2B1 6
2B2 1
3A 1
Mean BCVA—Coats eyes (whole
cohort)
0.30 ± 0.19 (20/40)
Mean BCVA—Stage 2A 0.13 ± 0.13 (20/27)
Mean BCVA—Stage 2B 0.44 ± 0.12 (20/55)
Mean BCVA—Stage 3A 2 (20/2000)
Mean BCVA—Fellow eyes 0.03 ± 0.07 (20/21)
BCVA, best-corrected visual acuity.
Table 2. Comparison of Vascular Density and Foveal
Avascular Zone Area in all 13 Coats Eyes Versus 13
Unaffected Fellow Eyes
Measurement Coats Eyes Fellow Eyes P
Vascular density SCP (%)
Whole image 43.7 ± 4.7 45.9 ± 4.4 0.000
Superior hemi 43.6 ± 4.8 45.7 ± 4.8 0.001
Inferior hemi 43.7 ± 4.9 46.1 ± 4.3 0.002
Fovea 22.7 ± 5.8 22.6 ± 5.7 0.872
Parafovea—total 45.7 ± 5.4 48.5 ± 4.7 0.000
Parafovea—sup-hemi 45.6 ± 5.2 48.5 ± 5.3 0.001
Parafovea—inf-hemi 45.7 ± 5.7 48.6 ± 4.5 0.002
Parafovea—temporal 44.1 ± 5.1 48 ± 5.0 0.000
Parafovea—superior 46.5 ± 5.3 49.3 ± 5.6 0.010
Parafovea—nasal 45.5 ± 5.7 48.1 ± 4.7 0.004
Parafovea—inferior 46.7 ± 6.2 49.1 ± 4.7 0.025
Vascular density DCP (%)
Whole image 43.0 ± 6.3 50.3 ± 2.2 0.001
Superior hemi 43.5 ± 5.7 50.4 ± 2.1 0.001
Inferior hemi 42.5 ± 7.1 50.3 ± 2.3 0.002
Fovea 30.6 ± 6.2 36.3 ± 6.0 0.000
Parafovea—total 44.5 ± 6.4 52.5 ± 2.0 0.001
Parafovea—sup-hemi 44.9 ± 5.9 52.7 ± 2.1 0.001
Parafovea—inf-hemi 44.1 ± 7.1 52.3 ± 2.1 0.001
Parafovea—temporal 42.8 ± 7.1 52.7 ± 2.3 0.000
Parafovea—superior 44.8 ± 5.7 52.6 ± 1.9 0.000
Parafovea—nasal 45.5 ± 6.5 52.7 ± 2.3 0.004
Parafovea—inferior 44.0 ± 7.5 52.0 ± 2.3 0.001
FAZ area (mm2) 0.29 ± 0.1 0.24 ± 0.09 0.003
Data in boldface had signiﬁcant values (p,0.05).
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Discussion
This study provides quantitative data of the vessel
density and FAZ in a pediatric population with Coats
disease. We found that in all patients, vascular density
was decreased in the eyes affected by Coats disease
compared with the fellow eyes. The FAZ area was also
signiﬁcantly larger in eyes with Coats disease in
comparison with fellow eyes. In a subgroup analysis,
we found that in patients with Stage, 2A there was
a decrease in vascular density in the DCP layer in
comparison with the fellow eyes, whereas in patients
with Stage 2B, the decrease in vascular density involved
both the SCP and DCP layers. The signiﬁcant differences
found in both vascular density and FAZ area between
eyes with Coats disease and fellow eyes lends further
evidence that Coats disease is a unilateral disease.
However, larger studies are required to support these
data.
Different studies quote different prevalence of
unilaterality in Coats disease ranging from 80% to
95%.4,22,23 This study also reiterates that in patients
with presumed bilateral Coats disease, one should
investigate secondary bilateral Coats disease–like ret-
inopathy with systemic conditions such as faciosca-
pulohumeral dystrophy.24
Decreased vascular density has been reported in
several retinal vascular diseases, including diabetic
retinopathy (DR) (mostly in the DCP),25,26 retinal vein
occlusion,27 and sickle cell retinopathy.28 It is not sur-
prising then that according to our data, Coats disease
exhibits the same changes to vascular density. In our
group of patients, the decrease in vascular density was
seen in both the superﬁcial plexus and the deep plexus
in patients with Stage 2B disease. According to the
accepted clinical classiﬁcation, Stage 2B disease in-
volves the macula.2 However, we also found a signif-
icant decrease in the vascular density in patients with
Stage 2A disease, which, according to the classiﬁca-
tion, should not involve the center. This is a new ﬁnd-
ing for this disease. Nevertheless, considering data
from different vascular diseases, it is not a surprise.
Optical coherence tomography angiography has
proven to be a sensitive device for the detection of
early subclinical changes in the macula. Vascular den-
sity changes are seen in diabetics even before the
development of overt DR.26 Our data suggest that such
subclinical changes also occur in Coats disease before
the apparent involvement of the macula as seen by
other imaging modalities and with biomicroscopy.
Interestingly, the DCP seems to be the ﬁrst layer
involved in the condition. This is consistent with
Table 3. Comparison of Vascular Density and Foveal Avascular Zone Area in 5 Coats Eyes With Stage 2A Disease Versus
5 Unaffected Fellow Eyes
Measurement Coats Eyes Fellow Eyes P
Vascular density SCP (%)
Whole image 45.6 ± 2.9 46.7 ± 2.3 0.158
Superior hemi 44.8 ± 3.9 46.4 ± 2.3 0.165
Inferior hemi 46.3 ± 2.0 47.1 ± 2.5 0.200
Fovea 21.4 ± 6.6 23.0 ± 5.8 0.228
Parafovea—total 48.2 ± 2.8 49.6 ± 2.0 0.114
Parafovea—sup-hemi 47.5 ± 4.0 49.5 ± 1.9 0.208
Parafovea—inf-hemi 48.8 ± 1.9 49.7 ± 2.5 0.133
Parafovea—temporal 46.2 ± 3.0 48.6 ± 2.9 0.035
Parafovea—superior 48.7 ± 4.3 50.5 ± 2.2 0.406
Parafovea—nasal 48.8 ± 1.6 49.3 ± 3.3 0.637
Parafovea—inferior 48.9 ± 2.9 49.9 ± 2.3 0.538
Vascular density DCP (%)
Whole image 46.7 ± 2.9 50.3 ± 2.2 0.023
Superior hemi 46.9 ± 3.1 50.5 ± 2.1 0.011
Inferior hemi 46.6 ± 3.1 50.1 ± 2.3 0.061
Fovea 30.9 ± 4.1 35.6 ± 4.0 0.001
Parafovea—total 48.7 ± 2.7 52.5 ± 1.8 0.013
Parafovea—sup-hemi 49.1 ± 3.3 52.9 ± 1.9 0.024
Parafovea—inf-hemi 48.3 ± 2.3 52.2 ± 1.7 0.013
Parafovea—temporal 49.5 ± 3.4 52.3 ± 2.2 0.054
Parafovea—superior 47.9 ± 2.9 53.4 ± 1.6 0.007
Parafovea—nasal 49.3 ± 3.0 52.4 ± 1.9 0.080
Parafovea—inferior 48.1 ± 2.1 52.2 ± 1.7 0.004
FAZ area (mm2) 0.29 ± 0.1 0.25 ± 0.1 0.012
Data in boldface had signiﬁcant values (p,0.05).
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previous studies that have shown more frequent and
more pronounced changes to vascular perfusion in the
DCP in both DR25 and retinal vein occlusion (RVO).29
Recent literature suggests that these ﬁndings are a result
of this layer being the most likely to be confounded by
projection artifacts and segmentation error.30 However,
given the use of the 3D PAR algorithm in our study,
designed to remove projection artifacts from deeper
layers, it is possible that such ﬁndings may be true.
Because the SCP is directly connected to the retinal
arterioles, it may have greater perfusion pressure than
the DCP.29 In addition, the DCP is located in a water-
shed-like area where oxygen saturation may be lower
than in the inner and outer retina,31 suggesting higher
vulnerability to ischemic or any other insults.
The FAZ area has been shown to be increased in
different retinal vascular diseases. Optical coherence
tomography angiography of 63 eyes of 64 patients
with diabetes mellitus showed signiﬁcant enlarge-
ment of FAZ from 0.25 mm2 in controls to 0.37 mm2
in diabetic eyes without DR, and to 0.38 mm2 in
eyes with DR.32 A study of 23 subjects with RVO
(15 central RVO and 8 branch RVO) and 8 eyes of 8
age-matched controls assessed FAZ size in both groups.
Mean FAZ was larger in RVO eyes than in both fellow
eyes and control eyes.29 In the above-mentioned study
comparing patients with sickle cell disease to normal
subjects, the FAZ area was signiﬁcantly larger in affected
eyes than in the control group.28
As with vascular density, our data suggest that
Coats disease also leads to FAZ enlargement similarly
to other retinal vascular diseases, a ﬁnding that is seen
as early as Stage 2A of the disease. The enlargement
may represent macular vessel compromise and serves
as an additional marker for central changes in this
disease. Longitudinal studies exploring the change of
FAZ and vessel density over time may provide a clue
of the threshold of these parameters below which
visible clinical ﬁndings occur.
Optical coherence tomography angiography has been
limited by various image artifacts. Projection artifacts, in
particular, pose a challenge, causing superﬁcial vessels to
be incorrectly detected as deeper vessels.33 This may
lead to erroneous quantiﬁcation at the level of the
DCP. The current study used AngioAnalytics research
software (Optovue), using the 3D PAR algorithm. This
algorithm has been shown to effectively reduce projec-
tion artifacts. Studies have demonstrated a decreased
two-dimensional correlation coefﬁcient between plex-
uses (indicating that the plexuses are more dissimilar)
and suppression of projection artifacts with reduced vas-
cular density measurements in the deeper layers, which
are mostly affected by projection artifacts.34
In addition, the AngioAnalytics version used in this
study includes a segmentation editing and propagation
tool, allowing for correction of automatic segmenta-
tion errors. This was used in two patients in our study,
one with a macular scar and the other with macular
edema. The data from these patients were similar to
that seen with the other patients not needing segmen-
tation correction. This technique may improve the
ability to analyze and follow-up on patients with
signiﬁcant macular changes, including Coats disease.
Our study was limited by a small sample size,
resulting from the rarity of the condition and the
elimination of patients with poor image quality.
However, this group was sufﬁcient to produce highly
signiﬁcant results, suggesting that the changes seen are
indeed real and substantial.
In conclusion, this is the ﬁrst study to provide
quantitative data of the macular vascular density and
FAZ area in a cohort of pediatric patients with Coats
disease to lend evidence to the unilaterality of Coats
disease and strengthen the evidence that a somatic
mutation is a likely explanation for the disease. The
ﬁndings in the eyes affected by Coats disease suggest
that this vascular condition behaves similarly to other
Table 4. Comparison of Vascular Density and Foveal
Avascular Zone Area in 7 Coats Eyes With Stage 2B
Disease Versus 7 Unaffected Fellow Eyes
Measurement Coats Eyes Fellow Eyes P
Vascular density
SCP (%)
Whole image 42.1 ± 5.7 44.7 ± 5.5 0.002
Superior hemi 42.4 ± 5.6 44.5 ± 6.1 0.002
Inferior hemi 41.7 ± 5.8 44.8 ± 5.3 0.008
Fovea 22.5 ± 5.3 20.6 ± 4.0 0.217
Parafovea—total 43.8 ± 6.6 47.4 ± 6.3 0.001
Parafovea—sup-
hemi
44.2 ± 6.2 47.3 ± 7.0 0.001
Parafovea—inf-hemi 43.5 ± 7.0 47.4 ± 5.7 0.007
Parafovea—temporal 42.2 ± 6.4 47.0 ± 6.7 0.000
Parafovea—superior 44.8 ± 6.0 48.1 ± 7.5 0.023
Parafovea—nasal 43.2 ± 6.9 46.8 ± 5.7 0.003
Parafovea—inferior 45.0 ± 8.0 48.1 ± 6.1 0.065
Vascular density
DCP (%)
Whole image 41.2 ± 7.2 49.9 ± 2.0 0.016
Superior hemi 42.1 ± 6.1 50.0 ± 2.2 0.019
Inferior hemi 40.4 ± 8.4 49.8 ± 2.1 0.015
Fovea 29.4 ± 7.3 34.9 ± 5.2 0.034
Parafovea—total 42.4 ± 7.1 52.1 ± 2.2 0.010
Parafovea—sup-
hemi
43.0 ± 5.8 52.2 ± 2.3 0.008
Parafovea—inf-hemi 41.9 ± 8.5 52.0 ± 2.4 0.013
Parafovea—temporal 38.1 ± 4.8 52.9 ± 2.8 0.000
Parafovea—superior 43.7 ± 6.1 51.8 ± 1.9 0.012
Parafovea—nasal 43.8 ± 7.4 52.5 ± 2.4 0.034
Parafovea—inferior 41.8 ± 9.2 51.6 ± 2.8 0.017
FAZ area (mm2) 0.31 ± 0.1 0.25 ± 0.1 0.046
Data in boldface had signiﬁcant values (p,0.05).
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retinal vascular diseases, with FAZ enlargement and
reduction in vascular density. However, the study also
provides evidence of overt macular changes at Stage
2A, which is currently classiﬁed clinically as a stage of
nonmacular involvement. Given its noninvasiveness,
OCTA may prove to be a valuable tool in the
evaluation and follow-up of pediatric patients with
Coats disease, including the potential impact of
treatment on macular vascular density.
Key words: Coats disease, OCTA, OCTA, PAR,
pediatric, unilateral.
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